(VIANEWS) – Shares of 10x Genomics (NASDAQ Composite: TXG) rose 5.09% to $145.87 at 15:00 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ Composite is jumping 2.12% to $15,299.18, after five successive sessions in a row of losses. This seems, so far, an all-around up trend exchanging session today.

10x Genomics’s last close was $138.80, 33.59% below its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 370090 which is 46.22% below its average volume of 688217.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was 1.92%, 0.43%, and 3.14%, respectively.

10x Genomics’s highest amplitude of average volatility was 2.91% (last week), 3.57% (last month), and 3.14% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be oversold (<=20).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $145.87 at 15:00 EST, way below its 52-week high of $208.99 and way above its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s worth is under its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here